81
70
Growth Score
-5 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
954782
Telomium is a biotechnology company developing a therapeutic product for cancer immunotherapy.
About the Company
Telomium is a biotechnology company developing a cancer immunotherapy product with a unique composition in the present pharmacopoeia: a ribonucleoprotein, which has the ability to mimic a viral attack and induce an auto-immune reaction targeted against any form of cancer, without causing significant side effects. This self-vectored and
self-adjuvanted vaccine is based on the telomerase ribonucleoprotein particle prepared from a patented, safe and competitive yeast-based technology using a breakthrough innovation in the production of the recombinant telomerase protein.
